###begin article-title 0
The Reno-Vascular A2B Adenosine Receptor Protects the Kidney from Ischemia
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Acute renal failure from ischemia significantly contributes to morbidity and mortality in clinical settings, and strategies to improve renal resistance to ischemia are urgently needed. Here, we identified a novel pathway of renal protection from ischemia using ischemic preconditioning (IP).
###end p 2
###begin title 3
Methods and Findings
###end title 3
###begin p 4
###xml 365 368 365 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 363 368 363 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1<sup>&#8722;/&#8722;</sup></italic>
###xml 373 376 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 370 376 370 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2A<sup>&#8722;/&#8722;</sup></italic>
###xml 385 388 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 381 388 381 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3AR<sup>&#8722;/&#8722;</sup></italic>
###xml 455 458 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 450 458 450 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
For this purpose, we utilized a recently developed model of renal ischemia and IP via a hanging weight system that allows repeated and atraumatic occlusion of the renal artery in mice, followed by measurements of specific parameters or renal functions. Studies in gene-targeted mice for each individual adenosine receptor (AR) confirmed renal protection by IP in A1-/-, A2A-/-, or A3AR-/- mice. In contrast, protection from ischemia was abolished in A2BAR-/- mice. This protection was associated with corresponding changes in tissue inflammation and nitric oxide production. In accordance, the A2BAR-antagonist PSB1115 blocked renal protection by IP, while treatment with the selective A2BAR-agonist BAY 60-6583 dramatically improved renal function and histology following ischemia alone. Using an A2BAR-reporter model, we found exclusive expression of A2BARs within the reno-vasculature. Studies using A2BAR bone-marrow chimera conferred kidney protection selectively to renal A2BARs.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
These results identify the A2BAR as a novel therapeutic target for providing potent protection from renal ischemia.
###end p 6
###begin p 7
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Using gene-targeted mice, Holger Eltzschig and colleagues identify the A2B adenosine receptor as a novel therapeutic target for providing protection from renal ischemia.
###end p 7
###begin title 8
Editors' Summary
###end title 8
###begin title 9
Background.
###end title 9
###begin p 10
###xml 828 836 <span type="species:ncbi:9606">patients</span>
Throughout life, the kidneys perform the essential task of filtering waste products and excess water from the blood to make urine. Each kidney contains about a million small structures called nephrons, each of which contains a filtration unit consisting of a glomerulus (a small blood vessel) intertwined with a urine-collecting tube called a tubule. If the nephrons stop working for any reason, the rate at which the blood is filtered (the glomerular filtration rate or GFR) decreases and dangerous amounts of waste products such as creatinine build up in the blood. Most kidney diseases destroy the nephrons slowly over years, producing an irreversible condition called chronic renal failure. But the kidneys can also stop working suddenly because of injury or poisoning. One common cause of "acute" renal failure in hospital patients is ischemia-an inadequate blood supply to an organ that results in the death of part of that organ. Heart surgery and other types of surgery in which the blood supply to the kidneys is temporarily disrupted are associated with high rates of acute renal failure.
###end p 10
###begin title 11
Why Was This Study Done?
###end title 11
###begin p 12
###xml 1007 1011 <span type="species:ncbi:10090">mice</span>
Although the kidneys usually recover from acute failure within a few weeks if the appropriate intensive treatment (for example, dialysis) is provided, acute renal failure after surgery can be fatal. Thus, new strategies to protect the kidneys from ischemia are badly needed. Like other organs, the kidneys can be protected from lethal ischemia by pre-exposure to several short, nonlethal episodes of ischemia. It is not clear how this "ischemic preconditioning" increases renal resistance to ischemia but some data suggest that the protection of tissues from ischemia might involve a signaling molecule called extracellular adenosine. This molecule binds to proteins called receptors on the surface of cells and sends signals into them that change their behavior. There are four different adenosine receptor-A1AR, A2AAR, A2BAR, and A3AR-and in this study, the researchers use ischemic preconditioning as an experimental strategy to investigate which of these receptors protects the kidneys from ischemia in mice, information that might provide clues about how to protect the kidneys from ischemia.
###end p 12
###begin title 13
What Did the Researchers Do and Find?
###end title 13
###begin p 14
###xml 158 161 158 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 154 161 154 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 168 171 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 163 171 163 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 178 181 178 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 173 181 173 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 187 194 187 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3AR<sup>&#8722;/&#8722;</sup></italic>
###xml 628 631 628 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 623 631 623 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 749 752 749 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 744 752 744 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 1065 1068 1065 1068 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1060 1068 1060 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
###xml 1046 1050 <span type="species:ncbi:10090">mice</span>
###xml 1069 1073 <span type="species:ncbi:10090">mice</span>
The researchers first asked whether ischemic preconditioning protects the kidneys of mice strains that lack the genes for individual adenosine receptors (A1AR-/-, A2AAR-/-, A2BAR-/-, and A3AR-/- mice) from subsequent ischemia. Using a hanging-weight system, they intermittently blocked the renal artery of these mice before exposing them to a longer period of renal ischemia. Twenty-four hours later, they assessed the renal function of the mice by measuring their blood creatinine levels, GFRs, and urine production. Ischemic preconditioning protected all the mice from ischemia-induced loss of kidney function except the A2BAR-/- mice. It also prevented ischemia-induced structural damage and inflammation in the kidneys of wild-type but not A2BAR-/- mice. These results suggest that A2BAR may help to protect the kidneys from ischemia. Consistent with this idea, ischemic preconditioning did not prevent ischemia-induced renal damage in wild-type mice treated with a compound that specifically blocks the activity of A2BAR. However, wild-type mice (but not A2BAR-/- mice) treated with an A2BAR agonist (which activates the receptor) retained their kidney function after renal ischemia without ischemic preconditioning. Finally, the researchers report that A2BAR has to be present on the blood vessels in the kidney to prevent ischemia-induced acute renal failure.
###end p 14
###begin title 15
What Do These Findings Mean?
###end title 15
###begin p 16
###xml 587 593 <span type="species:ncbi:9606">people</span>
###xml 657 665 <span type="species:ncbi:9606">patients</span>
###xml 745 751 <span type="species:ncbi:9606">people</span>
These findings suggest that the protection of the kidneys from ischemia and the renal resistance to ischemia that is provided by ischemic preconditioning involve adenosine signaling through A2BAR. They also suggest that adenosine might provide protection against ischemia-induced damage by blocking inflammation in the kidney although other possible mechanisms of action need to be investigated. Importantly, these findings suggest that A2BAR might be a therapeutic target for the prevention of renal ischemia. However, results obtained in animals do not always reflect the situation in people, so before A2BAR agonists can be used to reduce the chances of patients developing acute renal failure after surgery, these results need confirming in people and the safety of A2BAR agonists need to be thoroughly investigated.
###end p 16
###begin title 17
Additional Information.
###end title 17
###begin p 18
Please access these Web sites via the online version of this summary at .
###end p 18
###begin p 19
The US National Institute of Diabetes and Digestive and Kidney Diseases provides information on , including a list of links to further information about kidney disease
###end p 19
###begin p 20
The MedlinePlus encyclopedia has a page on (in English and Spanish)
###end p 20
###begin p 21
Wikipedia has pages on , , , and  (note that Wikipedia is a free online encyclopedia that anyone can edit; available in several languages)
###end p 21
###begin title 22
Introduction
###end title 22
###begin p 23
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b001">1</xref>
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b001">1</xref>
###xml 423 424 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b002">2</xref>
###xml 642 643 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b003">3</xref>
###xml 796 797 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b004">4</xref>
###xml 968 969 968 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b005">5</xref>
###xml 1102 1103 1102 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b006">6</xref>
###xml 1104 1105 1104 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b008">8</xref>
###xml 294 302 <span type="species:ncbi:9606">patients</span>
###xml 467 475 <span type="species:ncbi:9606">patients</span>
###xml 612 619 <span type="species:ncbi:9606">persons</span>
###xml 876 884 <span type="species:ncbi:9606">patients</span>
Acute renal failure is defined as a rapid decrease in the glomerular filtration rate (GFR), occurring over a period of minutes to days [1]. The causes of acute renal failure are classically divided into three categories, prerenal, postrenal, or intrinsic [1]. However, over 50% of hospitalized patients with acute renal failure suffer from renal ischemia leading to prerenal azotemia or "intrinsic" acute tubular necrosis [2]. In fact, a recent study of hospitalized patients revealed that only a mild increase in the serum creatinine level (0.3-0.4 mg/dl) is associated with a 70% greater risk of death than in persons without any increase [3]. Along these lines, surgical procedures requiring cross-clamping of the aorta and renal vessels are associated with a renal failure rate of up to 30% [4]. Similarly, acute renal failure after cardiac surgery occurs in up to 10% of patients under normal circumstances and is associated with dramatic increases in mortality [5]. Taken together, these data highlight the urgent need for additional therapeutic modalities to prevent renal injury from ischemia [6-8].
###end p 23
###begin p 24
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b009">9</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b010">10</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b011">11</xref>
###xml 486 487 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b009">9</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b010">10</xref>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b012">12</xref>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b018">18</xref>
###xml 1005 1008 1005 1008 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1001 1008 1001 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cd39<sup>&#8722;/&#8722;</sup></italic>
###xml 1016 1019 1016 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1012 1019 1012 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cd73<sup>&#8722;/&#8722;</sup></italic>
###xml 1065 1067 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b019">19</xref>
###xml 1068 1070 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b020">20</xref>
###xml 1356 1358 1356 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b021">21</xref>
###xml 1359 1361 1359 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b025">25</xref>
###xml 1390 1392 1390 1392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b019">19</xref>
###xml 1393 1395 1393 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b020">20</xref>
###xml 1396 1398 1396 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b026">26</xref>
###xml 1399 1401 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
###xml 1738 1740 1738 1740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b029">29</xref>
###xml 1837 1839 1837 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b030">30</xref>
###xml 858 862 <span type="species:ncbi:10090">mice</span>
###xml 962 966 <span type="species:ncbi:10090">mice</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
Extracellular adenosine has been implicated as a critical mediator of reno-vascular functions [9,10]. In most vascular beds adenosine causes vasodilatation (e.g., in the coronary circulation), thereby contributing to the metabolic control of organ perfusion [11]. In contrast, adenosine can cause vasoconstriction in the kidneys, a response that has been suggested to be an organ-specific version of metabolic control designed to restrict organ perfusion when transport work increases [9,10]. In addition, several studies of tissue protection from limited oxygen availability have suggested an anti-inflammatory and tissue protective role of extracellular adenosine, particularly during conditions of hypoxia [12-18]. Extracellular adenosine is derived mainly via enzymatic phosphohydrolysis of precursor nucleotides to adenosine. In fact, recent studies of mice with genetic deletion of enzymatic steps in extracellular adenosine generation revealed that these mice are more prone to renal ischemia (cd39-/- or cd73-/- mice) compared to their littermate controls [19,20]. Once released into the extracellular space, adenosine can activate four individual G-protein coupled receptors (A1AR, A2AAR, A2BAR, and A3AR). As such, previous studies have shown a critical role of extracellular adenosine generation and signaling in tissue protection from hypoxia [21-25] or during preconditioning [19,20,26-28], where pretreatment with short and repeated episodes of nonlethal ischemia (ischemic preconditioning [IP]) result in a robust protection from subsequent ischemic injury. At present, it remains unclear which ARs mediate renal protection from ischemia. Some studies suggest a role of signaling through myeloid A2AAR in renal protection [29], other studies found signaling through the A1AR in inhibiting renal inflammation and necrosis [30].
###end p 24
###begin p 25
###xml 213 217 213 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cd39</italic>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b027">27</xref>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cd73</italic>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b031">31</xref>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b032">32</xref>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b011">11</xref>
###xml 1209 1211 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b010">10</xref>
###xml 1212 1214 1212 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b033">33</xref>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b034">34</xref>
###xml 1377 1379 1377 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b035">35</xref>
###xml 1380 1382 1380 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b036">36</xref>
###xml 1471 1473 1471 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b037">37</xref>
###xml 1474 1476 1474 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b038">38</xref>
###xml 1805 1807 1805 1807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b027">27</xref>
###xml 1808 1810 1808 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
###xml 1811 1813 1811 1813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b039">39</xref>
###xml 2377 2379 2377 2379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b040">40</xref>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 2029 2035 <span type="species:ncbi:10090">murine</span>
###xml 2183 2187 <span type="species:ncbi:10090">mice</span>
Similarly to studies of renal protection by IP, previous studies in the heart have shown a critical role of extracellular adenosine generation in IP-dependent cardioprotection. For example, gene-targeted mice for cd39 [27] or cd73 [28] are not protected by cardiac IP-treatment. Moreover, a recent study compared myocardial infarct sizes in gene-targeted mice for each individual adenosine receptor (AR) and found a pivotal role of the A2BAR in attenuating ischemia-induced myocardial cell death [28]. In addition to its tissue-protective effects, extracellular adenosine signaling has been implicated in several cardio-specific functions including A1AR-dependent changes in cardiac conduction and heart rhythm (e.g., changes in P-R interval, atrio-ventricular blockade) [31], release of natriuretic peptide by cardiac myocytes [32], or the regulation of coronary blood flow by A2A or A2BARs [11]. In contrast, different functions of extracellular adenosine have been identified in the kidneys. For example, extracellular adenosine generation and signaling has been shown as a critical control point in the regulation of the tubulo-glomerular-feedback mechanisms, particularly through activation of the A1AR [10,33,34]. While adaptation of cardiac myocytes trigged by adenosine, bradykinin, and opioids-leading to activation of protein kinase C (PKC)-is central to cardiac IP [35,36], ischemic injury of the kidneys is characterized by vascular and renal-tubular injury [37,38], suggesting that preconditioning phenomena of the kidneys represent a form of vascular or reno-tubular adaptation. Therefore, previous studies of adenosine in IP-dependent cardioprotection have focused on histological assessment of myocardial cell death or leakage of myocardial specific enzymes into the systemic circulation [27,28,39], while studies of extracellular adenosine in reno-protection by IP require assessment of specific renal functions (e.g., glomerular filtration, tubular absorption, or secretion). Therefore, we recently developed a murine model of in situ IP and ischemia of the kidneys using a hanging weight system that allows repeated and atraumatic occlusion of the renal artery in mice, followed by measurements of specific parameters or renal function (e.g., GFR, creatinine clearance, urine production) to study molecular pathways of innate renal protection from ischemia [40].
###end p 25
###begin p 26
###xml 187 191 <span type="species:ncbi:10090">mice</span>
In the present studies, we utilized renal IP as an experimental strategy to identify adenosine signaling pathways to increase renal resistance to ischemia. Here, we studied gene-targeted mice for each individual AR for renal protection by IP.
###end p 26
###begin title 27
Methods
###end title 27
###begin title 28
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 28
###begin p 29
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR</italic>
###xml 411 416 411 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR</italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3AR</italic>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR</italic>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b041">41</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b043">43</xref>
###xml 924 926 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b044">44</xref>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">Mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 840 845 <span type="species:ncbi:10090">mouse</span>
###xml 917 921 <span type="species:ncbi:10090">mice</span>
All animal protocols were in accordance with the German guidelines for use of living animals and were approved by the Institutional Animal Care and Use Committee of the Tubingen University Hospital and the Regierungsprasidium Tubingen or the University of Colorado guidelines for animal care. In pharmacological studies, C57BL/6J mice obtained from Charles River Laboratories were used. Mice deficient in A1AR, A2BAR, or A3AR on the C57BL/6 strain, or deficient in A2AAR on the CD1 strain were generated, validated, and characterized as described previously [28,41-43]. For bone marrow chimeric studies, mice deficient in the A2AAR were backcrossed over six generations to C57BL/6. In all control experiments, age-, gender-, and weight-matched littermate controls were used. In subsets of experiments, a previously described A2BAR reporter mouse on the C57BL/6 strain was used (A2BAR-knock-out [KO]/beta-gal-knock-in mice) [44].
###end p 29
###begin title 30
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine Model for Renal IP
###end title 30
###begin p 31
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b040">40</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
Mice underwent right nephrectomy followed by left renal artery ischemia with or without prior IP treatment (four cycles of 4 min ischemia and 4 min reperfusion prior to 45 min of ischemia) using a hanging weight system, as previously described [40]. At the end of surgery, mice received 0.3 ml normal saline IP and were allowed to recover for 2 h under a heating lamp. Thereafter mice were placed into metabolic cages (Tecniplast Deutschland) for evaluation of renal function for 24 h, or mice were kept in standard cages for performing inulin clearance on the next day.
###end p 31
###begin title 32
Assessment of Renal Function
###end title 32
###begin p 33
###xml 239 240 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 246 247 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Plasma and urine creatinine were measured 24 h after renal ischemia using a commercially available colorimetric method (LT-SYS, Labor + Technik). From these data we calculated the creatinine clearance. Plasma and urine concentrations of Na+ and K+ were determined with a flame-emission photometer (ELEX 6361, Eppendorf AG). Renal excretory and hemodynamic values were calculated using standard formulas. Kidneys were harvested after 24 h and stored at -80 degreesC until further analysis.
###end p 33
###begin title 34
Inulin Clearance
###end title 34
###begin p 35
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b033">33</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b045">45</xref>
###xml 363 365 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b039">39</xref>
###xml 821 822 814 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1029 1030 1022 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1125 1126 1118 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1153 1154 1146 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
Inulin clearance was measured 24 h after renal ischemia (45 min, with or without prior IP treatment) as described previously [33,45]. Briefly, mice were anaesthetized using 50 mg/kg IP pentobarbital. Animals were then placed on a temperature-controlled operating table to keep rectal temperature at 37 degreesC. Tracheotomy was performed as described previously [39], and the right jugular vein was cannulated for continuous infusion. Blood samples were taken via a catheter inserted into the left femoral artery. A catheter was placed in the urinary bladder for timed urine collection after removal of the right kidney. After the surgery, all mice received a bolus of 0.85% sodium chloride solution in an amount equal to 20% of body weight. Continuous infusion was maintained at a rate of 600 mul/h/30g body weight, and 3H-inulin was added to the infusion for evaluation of whole kidney GFR. After stabilization of the animals for 20 min, 20-min timed urine collections were performed for determination of urinary flow rate and 3H-inulin. Blood was obtained in the middle of every urine collection period for measurement of 3H-inulin. Concentration of 3H-inulin in plasma and urine were performed by liquid phase scintillation counting, and GFR was calculated by standard formulas.
###end p 35
###begin title 36
Adenosine Measurement
###end title 36
###begin p 37
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cd73<sup>&#8722;/&#8722;</sup></italic>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b046">46</xref>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Whole kidneys from cd73-/- mice or age-, gender-, and weight-matched littermates were removed and immediately snap-frozen with clamps precooled to the temperature of liquid nitrogen with or without IP treatment prior to ischemia. The frozen kidneys were pulverized under liquid nitrogen, and the tissue protein was precipitated with 0.6 N ice-cold perchloric acid. Tissue adenosine levels were determined via HPLC as described previously [46].
###end p 37
###begin title 38
Renal Histology
###end title 38
###begin p 39
###xml 96 99 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 431 433 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b040">40</xref>
###xml 509 510 508 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 613 615 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b047">47</xref>
###xml 616 618 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b048">48</xref>
Kidneys were excised and harvested 24 h following 45 min of ischemia with or without IP in A2BAR-/- and their wild-type (WT) controls. Renal tissues were fixed in 4.5% buffered formalin, dehydrated, and embedded in paraffin. Sections (3 mum) were stained with hematoxylin and eosin (HE). For evaluation of granulocytic infiltrates, sections were stained by histochemistry using chloracetate esterase (CAE) as previously described [40]. Examination and scoring of three representative sections of each kidney (n = 4-6 for each condition) were carried out blinded to the experimental group as described previously [47,48].
###end p 39
###begin title 40
Immunofluorescence Histochemistry
###end title 40
###begin p 41
###xml 97 98 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</italic>
###xml 96 99 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;<italic>/</italic>&#8722;</sup>
###xml 325 331 <span type="species:ncbi:9986">rabbit</span>
###xml 441 447 <span type="species:ncbi:9913">bovine</span>
###xml 519 523 <span type="species:ncbi:9925">goat</span>
###xml 647 651 <span type="species:ncbi:9925">goat</span>
###xml 657 663 <span type="species:ncbi:9986">rabbit</span>
Kidneys were excised and harvested 24 h following 45 min of ischemia with or without IP in A2BAR-/- and their WT controls. The samples were cut in 5-mum slices, mounted on superfrost glass slides for immunohistochemistry, and stored at -20 degreesC. Immunofluorescence histochemistry was carried out using primary polyclonal rabbit anti-inducible nitric oxide synthase (iNOS) antibody (anti macNOS,Transduction Lab) at a 1:50 dilution in 1% bovine serum albumin (BSA) in PBS. The slides were pretreated with 10% normal goat serum for 1 h and then incubated in anti-iNOS antiserum at room temperature for 1 h. As secondary antibodies, FITC-labeled goat anti-rabbit antibodies (Dianova) were applied at 1:50 dilution in PBS at room temperature for 1 h. The primary antibody was omitted on the slides that served as negative controls. After mounting with Dako fluorescent mounting medium containing 15 Mm NaN3 (Dako-Patts), the slides were assessed for fluorescent microscopy. Expression of iNOS in inflammatory cells was assessed in ten randomly selected areas per sample, observed at 600x magnification using a scale system iNOS score: 0, no iNOS signal; 1, rare iNOS expression in macrophages; 2, moderate iNOS expression in three to five areas; 3, iNOS expression in five to eight areas; 4, strong iNOS expression in macrophages in all selected areas.
###end p 41
###begin title 42
Measurement of Nitrite/Nitrate Concentrations
###end title 42
###begin p 43
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 71 72 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Plasma and renal tissue concentrations of nitrite (NO2) and nitrate (NO3) were measured using a colorimetric-assay kit (Cayman Chemical Company).
###end p 43
###begin title 44
Renal Tissue Nitric Oxide Synthase Activity
###end title 44
###begin p 45
We measured nitric oxide synthase (NOS) activity in the renal tissue with a commercially available kit (Calbiochem, EMD Biosciences). The assay is based on the enzymatic conversion of nitrite to nitrate reductase, followed by the spectophotometric quantification of nitrite levels using the Griess reagent.
###end p 45
###begin title 46
Myeloperoxidase Activity
###end title 46
###begin p 47
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b040">40</xref>
To quantify neutrophil infiltration, we performed myeloperoxidase (MPO) measurements as previously described [40].
###end p 47
###begin title 48
ELISA (NFkappaB, IkappaBalpha) from Renal Tissue
###end title 48
###begin p 49
###xml 846 851 <span type="species:ncbi:10090">mouse</span>
The snap-frozen kidneys were thawed, weighed, and transferred to different tubes on ice containing 1 ml of T-PER (Tissue Protein Extraction Reagent, Pierce Biotechnology). The renal tissues were homogenized at 4 degreesC. Renal homogenates were centrifuged at 9,000 x g for 10 min at 4 degreesC. Supernatants were transferred to clean microcentrifuge tubes, frozen on dry ice, and thawed on ice. Total protein concentrations in the renal tissue homogenates were determined using a BCA (bicinchoninic acid) kit (Pierce Biotechnology). Renal tissue homogenates were diluted with 50% assay diluent and 50% T-PER reagent to a final protein concentration of 400 mug/ml. Activated NFkappaB (TransAM, Active Motif North America) and IkappaBalpha (TransAM, Active Motif North America) levels were measured in homogenates from whole renal tissues using a mouse ELISA kit according to the manufacturer's instructions.
###end p 49
###begin title 50
Compounds
###end title 50
###begin p 51
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
###xml 354 356 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
For specific inhibition of the A2BAR, PSB1115 (Tocris, Biotrend-Chemikalien) was administered IV via the jugular vein (5 mg/kg/h). This dosing regimen was previously shown to effectively inhibit A2BAR signaling [28]. In other experiments, a recently described A2BAR agonist (BAY 60-6583, Bayer HealthCare AG, 60 mug/kg IV via the jugular vein) was used [28].
###end p 51
###begin title 52
Transcriptional Analysis
###end title 52
###begin p 53
###xml 1380 1384 1374 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3AR</italic>
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 1843 1849 <span type="species:ncbi:10090">Murine</span>
For assessment of A1AR, A2AAR, A2BAR, and A3AR transcript levels as well as tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-6, keratinocyte-derived chemokine (KC, the mouse ortholog of human IL-8), and IL-10 transcript levels, total RNA was isolated and quantification of transcript levels were measured by real-time reverse transcription (RT)-PCR (iCycler, Bio-Rad Laboratories Inc.). In short, total RNA was isolated from renal tissue using the total RNA isolation NucleoSpin RNA II Kit according to the manufacturer's instructions (Macherey & Nagel). For this purpose, liquid nitrogen frozen tissue was homogenized in the presence of RA1 lysis buffer (Micra D8 homogenizer, ART-Labortechnik), and after filtration, lysates were loaded on NucleoSpin RNA II columns, followed by desalting and DNaseI digestion (Macherey & Nagel). RNA was washed, and the concentration was quantified. The PCR reactions contained 1 muM sense and 1 muM antisense oligonucleotides with SYBR Green I (Molecular Probes Inc.). Primer sets (sense sequence, antisense sequence, and transcript size, respectively) for the following genes were: A1AR (5'-AGG GAG GGG TCA AGA ACT GT-3', 5'-TCC CAG TCT CTG CCT CTG TT-3', 109 bp); A2AAR (5'-GAA GAC CAT GAG GCT GTT CC-3', 5'-GAG TAT GGG CCA ATG GGA GT-3', 253 bp); A2BAR (5'-GGA AGG ACT TCG TCT CTC CA-3', 5'-GGG CAG CAA CTC AGA AAA CT-3', 322 bp); A3AR (5'-CAA TTC GCT CCT TCT GTT CC-3', 5'-TCC CTG ATT ACC ACG GAC TC-3', 334 bp); IL-6 (ACCGCTATGAAGTTCCTCTC, CTCTCCGGACTTGTGAAGTA); TNF-alpha (ACTCCAGGCGGTGCCTATGT, TCCAGCTGCTCCTCCACTTG); IL-10 (CTTACTGACTGGCATGAGGA, GCATTAAGGAGTCGGTTAGC); KC (CCAAGCCTTGAGTCACAGAG, GGACAGCATCTGGCAGAATA). Each target sequence was amplified using increasing numbers of cycles of 94 degreesC for 1 min, 58 degreesC (for cytokines 60 degreesC) for 0.5 min, 72 degreesC for 1 min. Murine beta-actin mRNA (sense primer, 5'-ACA TTG GCA TGG CTT TGT TT-3' and antisense primer, 5'-GTT TGC TCC AAC CAA CTG CT-3') was amplified in identical reactions to control for the amount of starting template.
###end p 53
###begin title 54
Immunoblotting Experiments
###end title 54
###begin p 55
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 921 925 <span type="species:ncbi:9925">goat</span>
###xml 1101 1107 <span type="species:ncbi:9793">donkey</span>
###xml 1113 1117 <span type="species:ncbi:9925">goat</span>
###xml 1549 1554 <span type="species:ncbi:10090">mouse</span>
###xml 1571 1576 <span type="species:ncbi:9606">human</span>
In subsets of experiments, we determined renal A2BAR protein content. For this purpose, C57BL/6J mice were humanely killed following renal IP as above, and the kidney was excised at indicated time points (60, 120, and 240 min after IP) and immediately frozen at -80 degreesC. Tissues were homogenized and lysed for 10 min in ice-cold lysis buffer (150 mM NaCl, 25 mM Tris [pH 8.0], 5 mM EDTA, 2% Triton X-100, and 10% mammalian tissue protease inhibitor cocktail, Sigma-Aldrich), and collected in microfuge tubes. After spinning at 14,000 x g to remove cell debris, the pellet was resuspended in reducing Laemmli sample buffer and heated to 90 degreesC for 5 min. Samples were resolved on a 12% polyacrylamide gel and transferred to nitrocellulose membranes. The membranes were blocked for 1 h at room temperature in PBS supplemented with 0.2% Tween 20 (PBS-T) and 4% BSA. The membranes were incubated in 10 mug/ml A2BAR goat polyclonal antibody raised against the C terminus (Santa Cruz) for 1 h at room temperature, followed by 10 min washes in PBS. The membranes were then incubated in 1:3,000 HRP-donkey anti-goat Ig for A2BAR detection (Santa Cruz). The wash was repeated, and proteins were detected by enhanced chemiluminescence (Applied Biosystems). To control for protein loading, blots were stripped in stripping buffer for 15 min, washed ones for 10 min with TBST, and membrane was blocked for 1 h at room temperature in PBS supplemented with 0.2% Tween 20 (PBS-T) and 4% BSA. Thereafter the membrane was incubated with beta-actin using a mouse monoclonal anti-human beta-actin antibody (Abcam Inc.). The protein levels of beta-actin were detected by enhanced chemiluminescence.
###end p 55
###begin title 56
###xml 78 82 <span type="species:ncbi:10090">Mice</span>
Analysis of beta-Galactosidase Expression in Renal Sections of A2BAR Reporter Mice
###end title 56
###begin p 57
###xml 662 663 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 669 670 660 661 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 678 679 669 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 685 686 676 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 691 692 682 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 772 773 763 764 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">Mice</span>
###xml 486 491 <span type="species:ncbi:10090">mouse</span>
To localize the A2BAR in renal tissues, we analyzed beta-galactosidase expression in renal sections in A2BAR-KO/beta-gal-knock-in mice. Mice were anesthetized with isoflurane and perfused through the left heart ventricle with 20 ml of PBS (pH 7.4) at a rate of 4 ml/min. Perfusion for fixation with 30 ml of freshly made 2% paraformaldehyde in PBS (pH 7.4) was continued for 15 min at 2 ml/min and was followed by perfusion with PBS for 10 min. Kidneys were dissected from the perfused mouse and stored in ice-cold PBS, prior to staining for beta-galactosidase activity. Kidneys were cut into 1-2-mm thick slices, and stained with X-gal staining solution (5 mM K3Fe[CN]6, 5 mM K4Fe[CN]6 x 3H2O, [Sigma Aldrich, catalogue numbers P-8131 and P-9287, respectively], 2 mM MgCl2, in PBS) containing a final concentration of 1 mg/ml 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-gal, American Bioanalytical, catalogue number AB02400-1000). Samples were incubated at 37 degreesC for 2-4 h on a rocking platform. After staining, samples were rinsed with PBS and stored in 4% paraformaldehyde at 4 degreesC. Samples were embedded in paraffin and cut at a thickness of 5 mum. Thereafter sections were stained with HE.
###end p 57
###begin title 58
###xml 35 39 <span type="species:ncbi:10090">Mice</span>
Generation of Bone Marrow Chimeric Mice
###end title 58
###begin p 59
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
###xml 627 630 627 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 622 630 622 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 640 643 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 635 643 633 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 650 653 648 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 645 653 643 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 663 666 659 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 658 666 654 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 691 694 687 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 686 694 682 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 704 707 698 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 699 707 693 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 717 720 711 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 712 720 706 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 730 733 722 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 725 733 717 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 853 855 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b029">29</xref>
###xml 887 890 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 882 890 874 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 899 902 891 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 894 902 886 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 943 946 935 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 938 946 930 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>+/+</sup></italic>
###xml 955 958 947 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 950 958 942 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 1219 1220 1211 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1349 1352 1341 1344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">137</sup>
###xml 1401 1402 1393 1394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1747 1749 1739 1741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b049">49</xref>
###xml 1836 1837 1828 1829 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1872 1873 1864 1865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
###xml 986 990 <span type="species:ncbi:10090">mice</span>
###xml 1268 1272 <span type="species:ncbi:10090">mice</span>
###xml 1513 1517 <span type="species:ncbi:10090">mice</span>
###xml 1874 1878 <span type="species:ncbi:10090">mice</span>
###xml 2021 2025 <span type="species:ncbi:10090">mice</span>
This animal protocol was in accordance with the German guidelines for use of living animals and was approved by the Institutional Animal Care and Use Committee of the Tubingen University Hospital and the Regierungsprasidium Tubingen or the University of Colorado guidelines for animal care. To define the contribution of renal or hematopoietic A2BARs during renal ischemia or IP, we generated bone marrow chimeric mice in which bone marrow was ablated by radiation in WT mice (C57BL/6) followed by reconstitution with bone marrow derived from previously characterized mice gene-targeted for the A2BAR [28] and vice versa (A2BAR-/- --> A2BAR+/+, A2BAR+/+ --> A2BAR-/-). Experiments with A2BAR+/+ --> A2BAR+/+ and A2BAR-/- --> A2BAR-/- mice served as controls. Since myeloid A2AAR signaling has been suggested in the attenuation of renal ischemia injury [29], we also performed IP in A2BAR+/+ or A2BAR-/- transplanted with bone marrow from A2AAR+/+ or A2AAR-/- mice. In short, male donor mice (8-10 wk old, 20-25 g) were humanely killed, and the marrow from the tibia and femur were harvested by flushing the marrow cavity with sterile isotonic sodium chloride solution. The bone marrow cells were then centrifuged at 400g for 5 min, resuspended, and counted. Recipient mice (8-10 wk of age, 20-25 g) were irradiated with a total dose of 12 Gy from a 137Cs source. Immediately after irradiation, 10 x 106 BM cells/recipient were injected in 0.3 ml 0.9% sodium chloride into the jugular vein. The resulting chimeric mice were housed in microisolators for at least 7 wk before experimentation and fed with water containing tetracycline (100 mg/l) in the first 2 wk following BM transplantation. Consistent with other studies using a similar approach [49], preliminary experiments using the same conditioning regimen and transplanting CD45.1+ bone marrow into irradiated CD45.1- mice resulted in >95% chimerism in B cells, neutrophils, and monocytic cells, and approximately85% chimerism in CD4+ and CD8+ T cells of recipient mice (unpublished data).
###end p 59
###begin title 60
Data Analysis
###end title 60
###begin p 61
###xml 322 323 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 340 341 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 636 637 634 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Renal injury score data are given as median and range, all other data are presented as mean +/- SD. Renal injury was analyzed with the Kruskal-Wallis test, with follow-up pairwise comparisons by Wilcoxon-Mann-Whitney test. For all other outcomes, one-way ANOVA was used to perform comparisons among groups. A significant (p < 0.05) overall F-statistic was followed by Tukey's post-hoc, pairwise multiple comparison test. For the comparison of the different AR transcripts, pairwise comparisons were made between the control and treatment groups by Dunnett multiple comparison technique. All test are two-sided, with significance set at p </= 0.05. SPSS version 16.0.1 was used to perform all calculations.
###end p 61
###begin title 62
Results
###end title 62
###begin title 63
Extracellular Adenosine Levels Are Elevated with Renal IP Treatment
###end title 63
###begin p 64
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b019">19</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b027">27</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b050">50</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b052">52</xref>
###xml 215 223 215 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g001">Figure 1</xref>
###xml 565 569 565 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cd73</italic>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b023">23</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b052">52</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b053">53</xref>
###xml 812 815 812 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 808 815 808 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cd73<sup>&#8722;/&#8722;</sup></italic>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
Previous studies have suggested extracellular adenosine in renal protection by IP [19,27,50-52]. Therefore, we first measured renal adenosine levels in preconditioned or un-preconditioned renal tissues. As shown in Figure 1, renal adenosine tissue content was approximately 10-fold higher after renal IP as compared to baseline. Similarly, renal adenosine levels were also elevated in IP-treated renal tissues after 45 min of ischemia. To confirm the extracellular nature of these findings, we repeated this experiment in previously characterized mice deficient of cd73 [23,52]. In fact, CD73 metabolizes the extracellular conversion of adenosine monophosphate (AMP) to adenosine, and thus represents the pace-maker enzyme of extracellular adenosine generation [53]. We found that renal adenosine content in cd73-/- mice with IP or IP prior to ischemia was significantly lower compared to littermate controls, thereby confirming the extracellular nature of IP-dependent adenosine elevations. Taken together, these studies demonstrate extracellular elevations of adenosine with renal IP treatment.
###end p 64
###begin title 65
Renal Adenosine Tissue Content with IP Treatment with or without Subsequent Ischemia
###end title 65
###begin p 66
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cd73<sup>&#8722;/&#8722;</sup></italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Age-, gender-, and weight-matched cd73-/- mice or littermate controls (WT) were subjected to IP alone (IP) or IP followed by 45 min of ischemia (IP + I) using a hanging weight system for atraumatic occlusion of the left renal artery. The IP protocol consisted of four cycles of ischemia and reperfusion (4 min each).
###end p 66
###begin p 67
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 269 270 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 283 284 283 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistics: One-way ANOVA was used to perform comparisons among groups. The F-test results are F (5,22) = 210.34, p < 0.001. All statistically significant differences within groups were compared by Tukey's post-hoc test (p < 0.05) and were indicated with a bracket (*, p < 0.01; **, p < 0.001).
###end p 67
###begin title 68
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 40 44 <span type="species:ncbi:10090">Mice</span>
IP Is Selectively Abolished in A2BAR-/- Mice
###end title 68
###begin p 69
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b042">42</xref>
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 112 120 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b043">43</xref>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 127 135 127 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
###xml 150 153 150 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3AR<sup>&#8722;/&#8722;</sup></italic>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b041">41</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b040">40</xref>
###xml 619 627 619 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g002">Figure 2</xref>
###xml 629 630 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g002">2</xref>
###xml 855 858 855 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 850 858 850 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 966 969 966 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 961 969 961 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 976 984 976 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g002">Figure 2</xref>
###xml 1073 1081 1073 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 1104 1112 1104 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 1145 1153 1145 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 1171 1179 1171 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 1232 1237 1232 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR</italic>
###xml 1296 1299 1296 1299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1291 1299 1291 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 1385 1388 1385 1388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1380 1388 1380 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 1458 1466 1458 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 1484 1492 1484 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 1507 1515 1507 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 1746 1754 1746 1754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 1857 1865 1857 1865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 1954 1962 1954 1962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 2170 2178 2170 2178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 2316 2324 2316 2324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 2327 2328 2327 2328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2429 2432 2429 2432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2424 2432 2424 2432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 2439 2447 2439 2447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">Figure 3</xref>
###xml 2453 2454 2453 2454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g003">3</xref>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 814 818 <span type="species:ncbi:10090">mice</span>
###xml 859 863 <span type="species:ncbi:10090">mice</span>
###xml 970 974 <span type="species:ncbi:10090">mice</span>
###xml 1300 1304 <span type="species:ncbi:10090">mice</span>
###xml 1389 1393 <span type="species:ncbi:10090">mice</span>
###xml 2156 2160 <span type="species:ncbi:10090">mice</span>
###xml 2433 2437 <span type="species:ncbi:10090">mice</span>
To elucidate adenosine signaling pathways through individual ARs, we exposed previously described A1AR-/- [42], A2AAR-/- [43], A2BAR-/- [28], and A3AR-/- [41], mice to renal IP prior to ischemia. For this purpose, mice were subjected to 45 min of renal artery occlusion with or without prior IP (four cycles, 4 min ischemia, 4 min reperfusion) followed by 24 h of reperfusion until assessment of renal function. To avoid surgical trauma during the procedure, we utilized a recently described model of intermittent renal artery occlusion via a hanging-weight system for isolated renal artery occlusion [40]. As shown in Figure 2A-2D, plasma creatinine and GFR, assessed by inulin clearance, were improved by IP in all gene-targeted mice for individual ARs to a similar degree as their respective littermate control mice, with the notable exception of A2BAR-/- mice. In fact, attenuation of plasma creatinine and improved GFR with IP were completely abolished in A2BAR-/- mice (Figure 2C). In addition, the renal protective effects of IP as assessed by creatinine clearance (Figure 3A), urinary flow rate (Figure 3B), urinary excretion of sodium (Figure 3C), or potassium (Figure 3D) were abrogated following targeted deletion of the A2BAR. To confirm the absence of renal protection of IP in A2BAR-/- mice on a histological evaluation depicts level, we examined kidneys from WT or A2BAR-/- mice after 45 min of ischemia with and without previous IP (control: Figure 3E, WT without IP; Figure 3F, WT with IP; Figure 3G). Histological intact tubular cell morphology in kidneys with IP prior to ischemia (WT + IP) in contrast to kidneys without IP (WT - IP). Here, severe acute tubular necrosis-obvious from the loss of tubular cell nuclei (arrow in Figure 3F) in the cortex and outer medulla with destruction of the proximal tubular brush border-was observed (Figure 3F). In addition, hyaline cast formation, intraluminal necrotic cellular debris (arrow in Figure 3F), and casts containing brush border blebs could be seen in the cortex as well as in the outer medulla. In contrast, these signs of tubular damage were only sporadic and quantitatively mild in mice with IP (Figure 3G). Semiquantitative histological analysis demonstrated a reduction in the Jablonski index from 4 (range 3-4) without IP to 2 (range 1-3, Figure 3J, p < 0.05) with IP. This obvious improvement of renal histology by IP was completely abolished in A2BAR-/- mice (Figure 3H and 3I). Taken together, these data provide the first functional evidence for a critical role of the A2BAR in renal protection by IP.
###end p 69
###begin title 70
###xml 52 56 <span type="species:ncbi:10090">Mice</span>
Renal Ischemia and Preconditioning in Gene-Targeted Mice for Individual ARs
###end title 70
###begin p 71
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A1AR<sup>&#8722;/&#8722;</sup></italic>
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 50 58 50 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 64 71 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A3AR<sup>&#8722;/&#8722;</sup></italic>
###xml 512 515 512 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 507 515 507 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 520 521 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
(A-D) Previously characterized A1AR-/-, A2AAR-/-, A2BAR-/-, and A3AR-/- mice or their respective age-, weight-, and gender-matched littermate controls (WT) were subjected to right nephrectomy followed by 45 min of left renal artery ischemia with or without prior in situ IP (consisting of four cycles of 4 min ischemia followed by 4 min reperfusion). Plasma creatinine and GFR (as measured by inulin clearance) were obtained after 24 h of reperfusion. Note: Renal protection conferred by IP is abrogated in A2BAR-/- mice.
###end p 71
###begin p 72
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 212 213 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 277 278 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 295 296 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 328 329 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 373 374 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 406 407 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 421 422 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 455 456 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 473 474 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
Statistics: One-way ANOVA with Tukey's post-hoc test was performed (*, p < 0.001 versus WT + IP; **, p < 0.001 versus the respective gene targeted mice with IP). The F-test results are for plasma creatinine: (A) F (3,21) = 41.2, p < 0.001; (B) F (3,23) = 60.66, p < 0.001; (C) F (3,22) = 67.87, p < 0.001; (D) F (3,25) = 48.45, p < 0.001; and for GFR (A) F (3,20) = 79.34, p < 0.001; (B) F (3,21) = 59.12, p < 0.001; (C) F (3,22) = 109.75, p < 0.001; (D) F (3,22) = 93.43, p < 0.001.
###end p 72
###begin title 73
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 41 45 <span type="species:ncbi:10090">Mice</span>
Renal Function and Histology in A2BAR-/- Mice Exposed to Renal Ischemia or Preconditioning
###end title 73
###begin p 74
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR</italic>
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</italic>
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;<italic>/</italic>&#8722;</sup>
A2BAR-/- or age-, weight-, and gender-matched littermate controls (WT) were subjected to right nephrectomy followed by 45 min of left renal artery ischemia with or without prior in situ IP (consisting of four cycles of 4 min ischemia followed by 4 min reperfusion).
###end p 74
###begin p 75
Renal function tests and renal histology were obtained after 24 h of reperfusion. (A) Creatinine clearance.
###end p 75
###begin p 76
(B) Urinary flow rate.
###end p 76
###begin p 77
(C) Urinary sodium excretion.
###end p 77
###begin p 78
(D) Urinary potassium excretion.
###end p 78
###begin p 79
(E-I) Representative HE staining (400x and 800x). Tissue damage was characterized by loss of tubular cells, tubular cast, and tubular dilation (arrows). Slice thickness was 3 mum.
###end p 79
###begin p 80
(J) Quantification of histological tissue damage assessed by Jablonski index.
###end p 80
###begin p 81
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 128 136 128 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 156 157 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 179 180 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 198 199 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 231 232 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 297 298 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
Statistics: (A-D) One-way ANOVA with Tukey's post-hoc test was performed (*, p < 0.001 versus WT + IP; **, p < 0.001 versus the A2BAR-/- mice with IP). The F-test results are (A) F (4,28) = 207.93, p < 0.001; (B) F (4,26) = 50.96, p < 0.001; (C) F (4,25) = 57.65, p < 0.001; (D) F (4,25) = 57.65, p < 0.001.
###end p 81
###begin p 82
###xml 92 93 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 248 251 248 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 243 251 243 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
(J) Kruskal-Wallis nonparametric analysis (chi-square = 17.175, degree of freedom (df) = 4, p = 0.002) with follow-up pairwise comparisons by Wilcoxon-Mann-Whitney test was performed with *, p < 0.05 versus WT + IP and **, p < 0.05 versus the A2BAR-/- mice with IP.
###end p 82
###begin title 83
###xml 65 69 <span type="species:ncbi:10090">Mice</span>
Anti-inflammatory Effects of IP Are Abrogated in A2BAR Deficient Mice
###end title 83
###begin p 84
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b026">26</xref>
###xml 388 390 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b026">26</xref>
###xml 579 587 575 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g004">Figure 4</xref>
###xml 589 590 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g004">4</xref>
###xml 758 766 754 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g004">Figure 4</xref>
###xml 768 769 764 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g004">4</xref>
###xml 792 800 788 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g004">Figure 4</xref>
###xml 891 899 887 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g004">Figure 4</xref>
###xml 1077 1080 1073 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1072 1080 1068 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 1279 1282 1271 1274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1274 1282 1266 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 1289 1297 1281 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g005">Figure 5</xref>
###xml 1299 1300 1291 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g005">5</xref>
###xml 1460 1465 1452 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR</italic>
###xml 1511 1519 1503 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g005">Figure 5</xref>
###xml 1617 1619 1605 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b026">26</xref>
###xml 1727 1735 1711 1719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g005">Figure 5</xref>
###xml 1821 1824 1801 1804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1816 1824 1796 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 1831 1839 1811 1819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g005">Figure 5</xref>
###xml 2029 2031 2001 2003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b054">54</xref>
###xml 2199 2202 2163 2166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2194 2202 2158 2166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 2209 2217 2173 2181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g005">Figure 5</xref>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 1081 1085 <span type="species:ncbi:10090">mice</span>
###xml 1229 1233 <span type="species:ncbi:10090">mice</span>
###xml 1283 1287 <span type="species:ncbi:10090">mice</span>
###xml 1413 1417 <span type="species:ncbi:10090">mice</span>
###xml 1447 1451 <span type="species:ncbi:10090">mice</span>
###xml 1825 1829 <span type="species:ncbi:10090">mice</span>
###xml 2203 2207 <span type="species:ncbi:10090">mice</span>
After having shown that A2BAR-/- mice are not protected by renal IP, we next attempted to understand how A2BAR signaling can affect renal IP. Here, we considered a study showing an anti-inflammatory role of A2BAR signaling in hypoxic preconditioning [26]. In fact, Khoury et al. demonstrated that adenosine-dependent signaling pathways inhibit NFkappaB activation during preconditioning [26]. Based on the hypothesis, that A2BAR signaling may be critical in mediating anti-inflammatory effects of IP, we assessed renal inflammatory cell accumulation during ischemia. As shown in Figure 4A-4E, 45 min of renal ischemia followed by 24 h of reperfusion was associated with dramatic increases in renal granulocyte accumulation as shown in histological sections (Figure 4A-4E), granulocyte score (Figure 4F), and measurement of the polymorphonuclear leukocyte (PMN) marker myeloperoxidase (MPO) (Figure 4G). Pretreatment with IP resulted in a profound reduction in inflammatory cell accumulation. However, the anti-inflammatory effects of renal IP were completely abolished in A2BAR-/- mice. Along the same lines, renal transcript of pro-inflammatory cytokines TNF-alpha, IL-6, and KC were all attenuated following IP treatment of WT mice, whereas no changes with IP occurred in A2BAR-/- mice (Figure 5A-5C). In contrast, transcript levels of the anti-inflammatory cytokine IL-10 were elevated with IP treatment of WT mice, whereas IP in gene-targeted mice for the A2BAR did not alter renal IL-10 transcript levels (Figure 5D). Consistent with previous studies showing adenosine signaling in inhibiting NFkappaB activity [26], we found that increases of renal NFkappaB activity with ischemia were attenuated following IP treatment (Figure 5E). In contrast, IP-dependent inhibition of NFkappaB activation was abrogated in A2BAR-/- mice (Figure 5E). While a number of mechanisms have been suggested to mediate the endogenous inactivation of NFkappaB, each of these pathways converges on changes in the inducible degradation of IkappaB [54]. Thus, we determined whether A2BAR signaling influences IkappaB activity during IP. In fact, IP associated increase in renal IkappaB activity were attenuated in A2BAR-/- mice (Figure 5F). Taken together, these studies reveal A2BAR-dependent anti-inflammatory effects of renal IP.
###end p 84
###begin title 85
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 33 37 <span type="species:ncbi:10090">Mice</span>
Inflammatory Changes in A2BAR-/- Mice during Renal Preconditioning
###end title 85
###begin p 86
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
A2BAR-/- mice and their respective age-, weight-, and gender-matched littermate controls (WT) were subjected to right nephrectomy followed by 45 min of left renal artery ischemia with or without prior in situ IP (consisting of four cycles of 4 min ischemia followed by 4 min reperfusion).
###end p 86
###begin p 87
(A-E) Chloracetate esterase staining. Arrows indicate granulocytes (magnification 600x).
###end p 87
###begin p 88
(F) Quantification of granulocyte accumulation.
###end p 88
###begin p 89
(G) Quantification of neutrophil tissue accumulation by measurement of myeloperoxidase (MPO).
###end p 89
###begin p 90
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 182 183 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 239 242 239 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 234 242 234 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
Statistics: (F) Kruskal-Wallis nonparametric analysis (chi-square = 17.86, df = 4, p = 0.001) with follow-up pairwise comparisons by Wilcoxon-Mann-Whitney test was performed with *, p < 0.01 versus WT + IP and **, p < 0.01 versus the A2BAR-/- mice with IP.
###end p 90
###begin p 91
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 119 122 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 114 122 114 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
(G) One-way ANOVA with Tukey's post-hoc test was performed (*, p < 0.001 versus WT + IP; **, p < 0.001 versus the A2BAR-/- mice with IP). The F-test result is F (4,22) = 46.26, p < 0.001.
###end p 91
###begin title 92
Transcriptional Responses of Inflammatory Cytokines Measured in Renal Tissue
###end title 92
###begin p 93
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
###xml 340 345 <span type="species:ncbi:9606">human</span>
A2BAR-/- mice and their respective age-, weight-, and gender-matched littermate controls (WT) were subjected to right nephrectomy followed by 45 min of left renal artery ischemia with or without prior in situ IP (consisting of four cycles of 4 min ischemia followed by 4 min reperfusion). (A) TNF-alpha, (B) IL-6, (C) KC (mouse ortholog of human IL-8), and (D) IL-10 were assessed by real-time RT-PCR from renal tissues. Data were calculated relative to beta-actin and are expressed as fold change compared to sham-operated animals without IP treatment.
###end p 93
###begin p 94
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
(E) NFkappaB and (F) IkappaBalpha levels were evaluated in renal tissue homogenates using a mouse enzyme-linked immunosorbent assay (ELISA).
###end p 94
###begin p 95
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 148 156 148 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 265 266 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 284 285 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 299 300 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 332 333 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 349 350 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 368 369 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 386 387 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
Statistics: One-way ANOVA with Tukey's post-hoc test was performed (*, p < 0.001 versus WT + IP; #, p < 0.05 versus WT+IP; **, p < 0.001 versus the A2BAR-/- mice with IP). The F-test results are (A) F (4,15) = 39.28, p < 0.001; (B) F (4,15) = 53.40, p < 0.001; (C) F (4,15) = 201.01, p < 0.001; (D) F (4,15) = 61.46, p < 0.001; (E) F (4,15)= 75.76, p < 0.001; and (F) F (4,15) = 56.18, p < 0.001.
###end p 95
###begin title 96
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 76 80 <span type="species:ncbi:10090">Mice</span>
IP-Associated Attenuation of Nitric Oxide Pathways Is Abolished in A2BAR-/- Mice
###end title 96
###begin p 97
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b037">37</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b037">37</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b055">55</xref>
###xml 676 684 676 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g006">Figure 6</xref>
###xml 690 691 690 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g006">6</xref>
###xml 766 771 766 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR</italic>
###xml 773 781 773 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g006">Figure 6</xref>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g006">6</xref>
###xml 860 865 860 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR</italic>
###xml 890 893 890 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 885 893 885 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 900 908 900 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g006">Figure 6</xref>
###xml 1125 1128 1125 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1120 1128 1120 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 1135 1143 1135 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g006">Figure 6</xref>
###xml 1145 1146 1145 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g006">6</xref>
###xml 1147 1148 1147 1148 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
###xml 869 873 <span type="species:ncbi:10090">mice</span>
###xml 894 898 <span type="species:ncbi:10090">mice</span>
###xml 1129 1133 <span type="species:ncbi:10090">mice</span>
Previous studies of renal ischemia revealed that ischemic tissues and infiltrating inflammatory cells express iNOS and release reactive oxygen species and N-derived oxidants [37]. As such, inhibition of iNOS attenuates ischemia reperfusion injury [37]. In turn, oxidative stress is involved in the pathogenesis of ischemia-reperfusion injury by adding further insult to renal tissues and inducing the release of pro-inflammatory molecules, which recruit inflammatory cells into the interstitium [55]. Consistent with these studies, we found significant increases in plasma and renal tissue levels of nitrite/nitrate with renal ischemia, which were attenuated by IP-treatment (Figure 6A and 6B). However, attenuation by IP was abolished in gene-targeted mice for the A2BAR (Figure 6A and 6B). Similarly, iNOS activity was reduced in IP-treated renal tissues of A2BAR WT mice but not in A2BAR-/- mice (Figure 6C). Moreover, immuno-histochemistry revealed a strong immune-reactivity for iNOS in macrophages following ischemia. Macrophage infiltration and iNOS expression was reduced following IP treatment of WT but not of A2BAR-/- mice (Figure 6D-6I). Taken together, these studies suggest that IP-associated attenuation of nitric oxide production involves signaling through the A2BAR.
###end p 97
###begin title 98
Nitrite, Nitrate Plasma Concentrations, and Renal Tissue Content and Nitric Oxide Synthetase Activity in Renal Tissues
###end title 98
###begin p 99
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 343 344 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 361 362 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
A2BAR-/- mice and their respective age-, weight-, and gender-matched littermate controls (WT) were subjected to right nephrectomy followed by 45 min of left renal artery ischemia with or without prior in situ IP (consisting of four cycles of 4 min ischemia followed by 4 min reperfusion). (A) Plasma or (B) tissue concentrations of nitrite (NO2) and nitrate (NO3) were measured using colorimetric-assay kits.
###end p 99
###begin p 100
(C) Tissue nitric oxide synthetase (NOS) activity.
###end p 100
###begin p 101
(D-H) Immunohistochemical staining for iNOS.
###end p 101
###begin p 102
(I) iNOS expression score.
###end p 102
###begin p 103
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 128 136 128 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 156 157 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 179 180 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 197 198 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 212 213 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 263 264 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
Statistics: (A-C) One-way ANOVA with Tukey's post-hoc test was performed (*, p < 0.001 versus WT + IP; **, p < 0.001 versus the A2BAR-/- mice with IP). The F-test results are (A) F (4,22) = 89.90, p < 0.001; (B) F (4,30) = 32.41, p < 0.001; (C) F (4,25) = 36.54, p < 0.001.
###end p 103
###begin p 104
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 169 170 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 201 202 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 226 229 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 221 229 221 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
(I) Kruskal-Wallis nonparametric analysis (chi-square = 19.1, df = 4, p = 0.001) with follow-up pairwise comparisons by Wilcoxon-Mann-Whitney test was performed with *, p < 0.01 versus WT + IP and **, p < 0.05 versus the A2BAR-/- mice with IP.
###end p 104
###begin title 105
A2BAR Antagonist Treatment Abolishes Renal Protection by IP
###end title 105
###begin p 106
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b056">56</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
###xml 587 595 587 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g007">Figure 7</xref>
###xml 650 658 650 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g007">Figure 7</xref>
###xml 673 681 673 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g007">Figure 7</xref>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 367 373 <span type="species:ncbi:10090">murine</span>
After having shown a critical role of A2BAR-signaling in renal protection by IP in gene-targeted mice, we next pursued pharmacological approaches. For this purpose, we administered a highly selective, water soluble A2BAR antagonist PSB1115 [56] and treated WT mice with intravenous PSB1115, 5 mg/kg/h, a dose we had previously shown to be effective in inhibiting the murine A2BAR in vivo [28]. To determine a time-window of PSB115 in attenuating renal IP-protection, we administered PSB1115 or vehicle prior to the surgery, before ischemia, and 5 min and 2 h after ischemia. As shown in Figure 7, renal protective effects of IP on plasma creatinine (Figure 7A) and on GFR (Figure 7B) were abolished with PSB1115 treatment, when given before or early during reperfusion. These pharmacological studies confirm the critical role of A2BAR signaling for renal protection by IP.
###end p 106
###begin title 107
Pharmacological Studies of A2BAR Signaling during Renal Ischemia and Preconditioning
###end title 107
###begin p 108
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR</italic>
A2BAR antagonist (PSB1115): Age-, weight-, and gender-matched C57BL/6J underwent right nephrectomy. Prior to the surgery, immediately before ischemia, 5 min or 2 h after ischemia, they received the selective A2BAR antagonist PSB1115 (5 mg/kg, intravenous) or treatment with a vehicle control. They were exposed to 45 min of left renal artery ischemia with or without prior in situ IP (consisting of four cycles of 4 min ischemia followed by 4 min of reperfusion). (A) Plasma creatinine and (B) GFR as assessed by inulin clearance were obtained after 24 h of reperfusion.
###end p 108
###begin p 109
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 231 232 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
Statistics: One-way ANOVA with Tukey's post-hoc test was performed (*, p < 0.001 versus the respective group without IP; **, p < 0.001 versus WT mice with IP and with PSB115 treatment). The F-test results are (A) F (9,54) = 42.20, p < 0.001; (B) F (9,55) = 51.67, p < 0.001.
###end p 109
###begin title 110
A2BAR Agonist (BAY 60-6583) Improves Renal Function during Ischemia
###end title 110
###begin p 111
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
###xml 550 558 549 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g008">Figure 8</xref>
###xml 652 655 651 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 647 655 646 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 695 703 694 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g008">Figure 8</xref>
###xml 960 968 959 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g008">Figure 8</xref>
###xml 970 971 969 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g008">8</xref>
###xml 1105 1106 1104 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1115 1123 1114 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g008">Figure 8</xref>
###xml 1125 1126 1124 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g008">8</xref>
###xml 1147 1150 1146 1149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1142 1150 1141 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 1222 1230 1221 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g008">Figure 8</xref>
###xml 1232 1233 1231 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g008">8</xref>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
###xml 1151 1155 <span type="species:ncbi:10090">mice</span>
After having shown that selective inhibition of the A2BAR attenuates renal protection by IP, we next pursued a potential therapeutic role of a specific A2BAR agonist (BAY 60-6583). In fact, a recent study demonstrated selectivity and functional in vivo evidence of this compound [28]. Here, we treated C57BL/6J mice with a single intravenous bolus of BAY 60-6583 (60 mug/kg body weight) prior to the surgical procedure, directly before renal ischemia, and 5 min or 2 h after ischemia. BAY 60-6583 treatment resulted in a dramatic improvement of GFR (Figure 8A) and plasma creatinine levels (unpublished data). When this experiment was repeated in A2BAR-/- mice, no improvement in GFR was found (Figure 8A), confirming the specificity of the renal protective effects of BAY 60-6583 through A2BAR signaling. Semiquantitative histological analysis confirmed severe acute tubular necrosis without BAY 60-6583 treatment in WT mice (Jablonski index of 3, range 3-4, Figure 8B-8D). Treatment with BAY 60-6583 was associated with a significant attenuation of tubular destruction (Jablonski index of 2, range 1-3, p < 0.05, Figure 8B-8D). In contrast A2BAR-/- mice showed no reduction in tubular damage with BAY 60-6583 treatment (Figure 8B-8D). Moreover, renal protection from ischemia with BAY 60-6583 treatment was limited to a time window that ended during early reperfusion. Taken together, these studies provide strong rationale for therapeutically targeting the A2BAR during renal ischemia.
###end p 111
###begin title 112
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR</italic>
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 38 42 <span type="species:ncbi:10090">Mice</span>
A2BAR Agonist (BAY 60-6583). A2BAR-/- Mice or Age-, Weight-, and Gender-Matched Littermate Controls Underwent Right Nephrectomy followed by 45 min of Left Renal Artery Ischemia and 24 h of Reperfusion
###end title 112
###begin p 113
They underwent treatment with BAY 60-6583 (60 mug/kg intravenous) or vehicle control given before the surgery, immediately before ischemia, 5 min or 2h after ischemia.
###end p 113
###begin p 114
(A) GFR (as measured by inulin clearance and (B) Jablonski index for histological quantification of ischemic injury were obtained after 24 h of reperfusion.
###end p 114
###begin p 115
(C, D) Representative HE staining (400x and 800x) of renal histology following 45 min of ischemia with (+BAY) or without BAY 60-6583 (-BAY) given prior to ischemia are displayed.
###end p 115
###begin p 116
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
Statistics: (A) One-way ANOVA with Tukey's post-hoc test was performed (*, p < 0.01 versus the WT mice with BAY treatment, **, p < 0.001 versus WT mice with BAY treatment). The F-test results are (A) F (11,69) = 54.84, p < 0.001.
###end p 116
###begin p 117
###xml 72 73 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
(B) Kruskal-Wallis nonparametric analysis (chi-square = 61.08, df = 11, p < 0.001) with follow-up pairwise comparisons by Wilcoxon-Mann-Whitney test was performed with *, p < 0.01 versus WT mice with BAY treatment.
###end p 117
###begin title 118
Renal IP Is Associated with Selective Induction of the A2BAR
###end title 118
###begin p 119
###xml 188 189 188 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 362 370 362 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g009">Figure 9</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g009">9</xref>
###xml 374 375 374 375 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 523 524 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 533 541 533 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g009">Figure 9</xref>
###xml 656 664 656 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g009">Figure 9</xref>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g009">9</xref>
###xml 675 676 675 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g009">9</xref>
###xml 793 801 793 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g009">Figure 9</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b024">24</xref>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
After having demonstrated A2BAR-dependent signaling pathways in renal protection by IP, we next investigated transcriptional consequences of renal IP on expressional levels of all four ARs. For this purpose, renal tissues were harvested at indicated time points following IP-treatment and transcript levels of individual ARs were determined by real-time RT-PCR (Figure 9A-9D). These studies revealed prompt and selective induction of the A2BAR transcript following renal IP (approximately 6-fold induction 60 min after IP, p < 0.05, Figure 9C). In contrast, mRNA levels for the A1AR, A2AAR, and A3AR remained unchanged following 60, 120, or 240 min of IP (Figure 9A, 9B, and 9D). In addition, Western blot analysis of A2BAR protein from preconditioned renal tissues confirmed A2BAR induction (Figure 9E). Consistent with previous work showing selective A2BAR induction with vascular hypoxia [24] or myocardial IP [28], these studies reveal induction of A2BAR transcript and protein with renal IP treatment.
###end p 119
###begin title 120
Transcriptional Responses to Renal IP and Expression of the A2BAR within the Kidneys
###end title 120
###begin p 121
###xml 49 53 <span type="species:ncbi:10090">mice</span>
(A-D) Age-, gender-, and weight-matched C57BL/6J mice were subjected to right nephrectomy followed by in situ IP with a hanging weight system for atraumatic occlusion of the left renal artery. The IP protocol consisted of four cycles of ischemia/reperfusion (4 min each), followed by indicated times of reperfusion. Transcriptional responses of the A1AR, A2AAR, and A2BAR of the A3AR were assessed by real-time RT-PCR. Data were calculated relative to beta-actin and are expressed as fold change compared to sham-operated animals without IP treatment.
###end p 121
###begin p 122
(E) Western blotting for renal A2BAR following IP treatment. Kidneys were excised at indicated times, flash frozen, and lysed; proteins were resolved by SDS PAGE and transferred to nitrocellulose. Membranes were probed with anti-A2BAR antibody. The same blot was reprobed for beta-actin as a control for protein loading. One representative experiment of three is shown.
###end p 122
###begin p 123
###xml 384 387 372 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 379 387 367 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
(F-I) A previously described A2BAR reporter mouse was used (A2BAR-KO/beta-gal-knock-in mice). Renal tissues were prepared and stained for beta-galactosidase (beta-Gal) as indicative of the A2BAR gene promoter, which drives the expression of this reporter gene. Procedures are as detailed under Methods. (F, G) beta-Gal staining of kidney derived from littermate controls (WT) or A2BAR-/- mice, and captured at the indicated magnifications (16 x) with an Olympus IX70 microscope combined with Hamamatsu charge-coupled device camera C4742-95.
###end p 123
###begin p 124
###xml 207 211 <span type="species:ncbi:10090">mice</span>
(H, I) HE-staining histological examination of renal sections derived from the kidney shown in upper panel. Arrows point to beta-Gal stained blood vessels. Fold magnification of captured images are 600x. WT mice were subjected to similar staining showing no expression. beta-Gal expression in kidney is clear and localized only in blood vessels.
###end p 124
###begin p 125
###xml 74 75 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 169 170 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Statistics: (A-D) One-way ANOVA with Dunn's multiple comparison test (**, p < 0.001 versus control WT mice without IP [C]). The F-test results are (A) F (3,17) = 19.82, p < 0.001.
###end p 125
###begin title 126
###xml 26 30 <span type="species:ncbi:10090">Mice</span>
Studies in A2BAR Reporter Mice Confer A2BAR Expression to the Reno-Vasculature
###end title 126
###begin p 127
###xml 316 318 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b044">44</xref>
###xml 466 474 460 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g009">Figure 9</xref>
###xml 476 477 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g009">9</xref>
###xml 231 236 <span type="species:ncbi:10090">mouse</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
On the basis of the above studies showing induction of the renal A2BAR with preconditioning, we were interested to define, which tissues express the A2BAR within the kidneys. Here, we used a previously characterized A2BAR reporter mouse (A2BAR-KO/beta-gal-knock-in mice) or their respective littermate control mice [44]. Surprisingly, beta-gal staining could only be detected within the reno-vasculature. In contrast, renal epithelia stained negative for the A2BAR (Figure 9F-9I). Taken together, these studies reveal for the first time, to our knowledge, a selective reno-vascular expression of the A2BAR within the kidneys.
###end p 127
###begin title 128
###xml 39 43 <span type="species:ncbi:10090">Mice</span>
Renal IP in A2BAR Bone-Marrow Chimeric Mice
###end title 128
###begin p 129
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b044">44</xref>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR</italic>
###xml 357 360 357 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 370 373 368 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 515 524 513 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g010">Figure 10</xref>
###xml 530 532 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g010">10</xref>
###xml 591 594 589 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 586 594 584 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 604 607 600 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 599 607 595 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 630 633 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 625 633 621 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 640 649 636 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g010">Figure 10</xref>
###xml 655 657 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g010">10</xref>
###xml 769 771 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b044">44</xref>
###xml 848 851 844 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 843 851 839 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 861 864 855 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 856 864 850 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 937 940 931 934 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 932 940 926 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 947 956 941 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g010">Figure 10</xref>
###xml 962 964 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g010">10</xref>
###xml 1052 1055 1046 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1047 1055 1041 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 1065 1068 1057 1060 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1060 1068 1052 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
###xml 874 878 <span type="species:ncbi:10090">mice</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
###xml 1078 1082 <span type="species:ncbi:10090">mice</span>
On the basis of these studies showing reno-vascular expression of the A2BAR and other studies showing myeloid A2BAR expression, particularly on macrophages [44], we studied the contribution of renal or hematopoietic A2BAR signaling to renal protection during ischemia or IP. For this purpose, we generated A2BAR bone marrow chimeric mice. As expected, A2BAR+/+ --> A2BAR+/+ chimeric mice showed a similar degree of renal protection (attenuated plasma creatinine and improved GFR) following IP treatment as WT mice (Figure 10A and 10B). Moreover, renal protection by IP was abrogated in A2BAR-/- --> A2BAR-/- mice, similar to A2BAR-/- mice (Figure 10A and 10B). Surprisingly, and in contrast to previous studies showing myeloid A2BAR signaling in vascular inflammation [44], renal protection by IP was conferred solely to renal A2BAR. In fact, A2BAR-/- --> A2BAR+/+ chimeric mice showed a similar degree of renal protection by IP as A2BAR+/+ mice (Figure 10A and 10B). In contrast, renal resistance to ischemia was not increased by IP treatment of A2BAR+/+ --> A2BAR-/- chimeric mice. Taken together, these studies suggest a critical role of renal A2BARs (as opposed to hematopoietic) in mediating the protective effects of IP.
###end p 129
###begin title 130
###xml 65 69 <span type="species:ncbi:10090">Mice</span>
Renal Ischemia and Preconditioning in A2BAR Bone Marrow Chimeric Mice
###end title 130
###begin p 131
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR</italic>
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 49 52 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 44 52 42 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 69 72 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 64 72 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 80 83 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 75 83 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 100 103 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 95 103 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 111 114 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 106 114 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 134 137 122 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 129 137 117 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 145 148 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 140 148 126 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">Mice</span>
A2BAR bone marrow chimeric mice [A2BAR+/+-->A2BAR+/+ [WT-->WT], A2BAR-/--->A2BAR-/- [KO-->KO], A2BAR-/--->A2BAR+/+ [KO-->WT] and A2BAR+/+-->A2BAR-/- [WT-->KO]) were generated. Experiments were performed 8 wk following transplantation. Mice underwent right nephrectomy and underwent 45 min of left renal artery ischemia with or without prior IP (consisting of four cycles of 4 min ischemia followed by 4 min reperfusion). Following 24 h of reperfusion time, (A) plasma creatinine and (B) GFRs were measured.
###end p 131
###begin p 132
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Influence of A2BAR agonist (BAY 60-6583) on renal function in bone marrow chimeric mice exposed to ischemia. A2BAR bone marrow chimeric mice were subjected to 45 min of ischemia with or without treatment with A2BAR agonist BAY 60-6583 (60 mug/kg intravenous). Following 24 h of reperfusion, (C) plasma creatinine, (D) GFR, and (E) histological tissue injury (Jablonski index) were obtained.
###end p 132
###begin p 133
###xml 78 79 78 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 132 133 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 253 254 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 271 272 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistics: (A-D) One-way ANOVA with Tukey's post-hoc test was performed (**, p < 0.001 versus the respective group without IP. The F-test results are (A) F (7,40)= 24.82, p < 0.001; (B) F (7,40) = 48.04, p < 0.001; (C) F (3,20) = 15.54, p < 0.001; (D) F (3,20) = 20.88, p < 0.001.
###end p 133
###begin p 134
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
(E) Kruskal-Wallis nonparametric analysis (chi-square = 12, df = 3, p = 0.007) with follow-up pairwise comparisons by Wilcoxon-Mann-Whitney test was performed with *, p < 0.05 versus WT mice with BAY treatment.
###end p 134
###begin title 135
Increased Resistance to Renal Ischemia with A2BAR Agonist BAY 60-6853 Treatment Requires Renal A2BARs
###end title 135
###begin p 136
###xml 350 353 350 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 345 353 345 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 363 366 361 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 358 366 356 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 536 539 533 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 531 539 528 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 546 555 543 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g010">Figure 10</xref>
###xml 557 559 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g010">10</xref>
###xml 702 705 699 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 697 705 694 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 715 718 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 710 718 705 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 794 803 789 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g010">Figure 10</xref>
###xml 805 807 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g010">10</xref>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 855 859 <span type="species:ncbi:10090">mice</span>
To further define the contribution of renal or hematopoietic A2BARs to renal protection from ischemia, we next performed studies of renal ischemia in A2BAR bone-marrow chimeric mice pretreated with the selective A2BAR agonist BAY 60-6853. Bone marrow chimeric A2BAR mice expressing the A2BAR on the tissues but not on their hematopoietic cells (A2BAR-/- --> A2BAR+/+ mice) showed dramatic improvement in renal function with BAY 60-6583 pretreatment (60 mug/kg) as assessed by plasma creatinine, GFR, and renal histology-similar to A2BAR+/+ mice (Figure 10C-10E). In contrast, BAY 60-6583 pretreatment of A2BAR bone marrow chimeric mice with the A2BAR expressed exclusively on hematopoietic cells (A2BAR+/+ --> A2BAR-/- mice) lacked any measurable improvement of renal function during ischemia (Figure 10C-10E). Together with our studies in A2BAR reporter mice showing exclusive expression of the renal A2BAR within the vasculature, these data suggest that signaling through the reno-vascular A2BAR is a critical control point for attenuating acute renal failure from ischemia.
###end p 136
###begin title 137
Renal Ischemia Reperfusion Injury Involves Myeloid A2AAR Signaling, While Preconditioning Is Conferred to Renal A2BARs
###end title 137
###begin p 138
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b029">29</xref>
###xml 373 376 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 368 376 368 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 385 388 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 380 388 380 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 421 424 421 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 416 424 416 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 433 436 433 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 428 436 428 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>+/+</sup></italic>
###xml 643 652 643 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g011">Figure 11</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g011">11</xref>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
On the basis of previous studies showing a critical role of myeloid A2AAR signaling in attenuating renal ischemia reperfusion injury [29] and the above results, we pursued the hypothesis that myeloid A2AAR signaling attenuates renal ischemia-reperfusion injury, while renal A2BAR signaling is important for preconditioning phenomena. For this purpose, we transplanted A2BAR-/- or A2BAR+/+ mice with bone marrow from A2AAR-/- or A2AAR+/+ mice. Consistent with the above hypothesis, these studies revealed that reno-protection by IP required renal A2BAR signaling, while mice without a myeloid A2AAR had more severe ischemia reperfusion injury (Figure 11A and 11B).
###end p 138
###begin title 139
###xml 70 74 <span type="species:ncbi:10090">Mice</span>
Renal Ischemia and Preconditioning in A2A/A2B AR Bone Marrow Chimeric Mice
###end title 139
###begin p 140
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>+/+</sup></italic>
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2BAR<sup>&#8722;/&#8722;</sup></italic>
###xml 139 142 139 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 134 142 134 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>+/+</sup></italic>
###xml 159 162 159 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 154 162 154 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A2AAR<sup>&#8722;/&#8722;</sup></italic>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10090">Mice</span>
A2BAR+/+ (A2BWT) or A2BAR-/- (A2BKO) mice underwent lethal radiation followed by bone marrow transplantation with marrow derived from A2AAR+/+ (A2AWT) or A2AAR-/- (A2AKO) mice. Experiments were performed 8 wk following transplantation. Mice underwent right nephrectomy and underwent 45 min of left renal artery ischemia with or without prior IP (consisting of four cycles of 4 min ischemia followed by 4 min reperfusion). Following 24 h of reperfusion time, (A) plasma creatinine and (B) GFRs were measured.
###end p 140
###begin p 141
###xml 72 73 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 159 160 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 182 183 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 200 201 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 215 216 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 233 234 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistics: One-way ANOVA with Tukey's post-hoc test was performed (**, p < 0.001 versus the respective group with IP; *, p < 0.001 versus A2AWT-->A2BKO). The F-test results are (A) F (7,40) = 32.45, p < 0.001; (B) F (7,40) = 29.67, p < 0.001.
###end p 141
###begin title 142
Discussion
###end title 142
###begin p 143
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b040">40</xref>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b019">19</xref>
###xml 770 772 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b020">20</xref>
###xml 1503 1505 1503 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b027">27</xref>
###xml 1506 1508 1506 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
###xml 1509 1511 1509 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b035">35</xref>
###xml 1512 1514 1512 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b036">36</xref>
###xml 1515 1517 1515 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b057">57</xref>
###xml 1194 1199 <span type="species:ncbi:10090">mouse</span>
In the present study, we investigated endogenous pathways for renal protection from ischemia. For this purpose, we utilized a recently developed model of renal IP via isolated renal artery occlusion by use of a hanging weight system, which allows for highly reproducible renal injury [40]. While previous studies on IP in the heart have focused on histological measurements of myocardial cell death or leakage of myocardial specific enzymes into the systemic circulation, this model allowed us to assess the consequences of IP-treatment on the preservation of specific renal functions, such as GFR, urinary sodium or potassium excretion, or urine production. On the basis of previous work showing extracellular adenosine generation in renal protection from ischemia [19,20], we tested the contribution of signaling through individual ARs to renal protection from ischemia by IP. Using genetic and pharmacological approaches, these studies revealed a pivotal role of the A2BAR. In fact, selective A2BAR agonist treatment provided a similar degree of renal protection from ischemia as IP treatment itself, suggesting that A2BAR agonists "precondition" the kidneys. Finally, the use of a reporter mouse model and studies in bone marrow A2BAR chimera helped to pinpoint the source of A2BAR protection to the reno-vasculature. This vascular phenotype was a surprising finding, as previous studies in the heart have conferred preconditioning phenomena mainly towards a metabolic adaptation of the myocardium [27,28,35,36,57]. In contrast, the present studies have revealed a critical contribution of the reno-vascular A2BAR to renal IP protection. Taken together, these data provide what we believe to be a previously not appreciated role of reno-vascular A2BAR signaling in enhancing renal resistance to ischemia and provide strong rationale for therapeutically targeting the A2BAR during renal ischemia.
###end p 143
###begin p 144
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b058">58</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b059">59</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b060">60</xref>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b061">61</xref>
###xml 698 701 698 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 695 701 695 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cd3<sup>&#8722;/&#8722;</sup></italic>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b060">60</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b061">61</xref>
###xml 737 740 737 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 735 740 735 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AR<sup>&#8722;/&#8722;</sup></italic>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b061">61</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b026">26</xref>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
Presently, the molecular mechanism of how renal A2BAR signaling attenuates renal injury from ischemia remains unknown. As previous studies have shown an important role of erythropoietin in tissue adaptation to hypoxia [58] or preconditioning [59], it would be tempting to speculate that extracellular adenosine generation and signaling (e.g., through the A2BAR) could influence renal erythropoietin secretion, e.g., as part of an autocrine feedback loop. However, recent work tested the influence of adenosine generation and signaling on renal erythropoietin release using genetic and pharmacological approaches [60,61]. These studies revealed that targeting extracellular adenosine generation (cd3-/- mice) [60,61] or individual ARs (AR-/- mice) [61] did not influence stimulated erythropoietin release. Taken together these studies rule out a contribution of extracellular adenosine generation or signaling on renal erythropoietin release. On the other hand, a study on extracellular adenosine in hypoxic preconditioning uncovered a novel molecular pathway of how adenosine signaling through the A2BAR can promote tissue adaptation to limited oxygen availability [26]. In this study, the authors investigated hypoxic precondition as a form of endogenous protection that renders cells tolerant to subsequent and more severe challenges of hypoxia. In order to define anti-inflammatory properties of preconditioning, the authors identified a cluster of NFkappaB-regulated genes whose expression was attenuated by preconditioning. Subsequent studies revealed that preconditioning-elicited protection was conferrable, as a soluble supernatant from preconditioned cells, and the active fraction identified as adenosine. Guided by recent studies demonstrating bacterial inhibition of NFkappaB through cullin-1 (Cul-1) deneddylation, they found a dose-dependent deneddylation of Cul-1 mediated by signaling through the A2BAR, suggesting that extracellular accumulation of adenosine and signaling through the A2BAR suppresses NFkappaB activity via deneddylation of Cul-1. These results are consistent with our present study showing that A2BAR-dependent signaling pathways are important for the anti-inflammatory properties of renal IP.
###end p 144
###begin p 145
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b036">36</xref>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b057">57</xref>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b062">62</xref>
###xml 1176 1185 1176 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g006">Figures 6</xref>
###xml 1190 1191 1190 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050137-g007">7</xref>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
However, renal A2BAR signaling could also involve other (and also faster) mechanisms of renal protection other than modulating inflammation. Based on the fact that dead tissues may themselves cause the induction of inflammation, the observed inflammatory infiltrates may well be a result of dead and dying cells rather than the cause of cell death. Moreover, the studies of bone-marrow chimeric A2BAR mice also tended to support inflammation as an effect rather than a cause as the receptors responsible for the protection were found not to be on the marrow-derived cells but on the reno-vasculature. As such, considerable evidence now indicates that IP-protection in the heart may be the result of preservation of the cardiac mitochondria by preventing permeability transition pore formation, which normally occurs in the first minutes of reperfusion [36,57,62]. Therefore, similar mechanisms could be accounting for the reno-protective effects observed in the kidneys. Moreover, the fact that abolished renal protection with A2BAR antagonist treatment and reno-protective effects with A2BAR agonist treatment are limited to a time window that ends during early reperfusion (Figures 6 and 7) speaks in favor for such mechanisms.
###end p 145
###begin p 146
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b044">44</xref>
###xml 787 789 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b044">44</xref>
###xml 1210 1212 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b044">44</xref>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
The present study is consistent with previous work showing an anti-inflammatory role of vascular A2BAR signaling. In fact, a study by Yang et al. used an "A2BAR-knockout/reporter gene-knock-in" approach to study the role of the A2BAR in inflammatory models [44]. The authors found highest expressional levels of the A2BAR in the vasculature and on macrophages. In addition, genetic deletion of the A2BAR was associated with low-grade vascular inflammation, augmentation of pro-inflammatory cytokines such as TNF-alpha, and a consequent down-regulation of IkappaBalpha in addition to up-regulation of adhesion molecules of the vasculature. Consistent with the present study on renal protection by IP, vascular inflammation was significantly increased in mice gene-targeted for the A2BAR [44]. Moreover, the authors showed that exposure to endotoxin resulted in augmented pro-inflammatory cytokine levels in gene-targeted mice. However, and in contrast to the present studies showing a critical role of the reno-vascular A2BAR in providing renal protection from ischemia, Yang et al. found that bone marrow (and to a lesser extent vascular) A2BARs regulated the low grade inflammation observed in their studies [44].
###end p 146
###begin p 147
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b063">63</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b064">64</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b027">27</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b028">28</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b063">63</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b064">64</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b029">29</xref>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b051">51</xref>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b065">65</xref>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b029">29</xref>
###xml 916 918 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b065">65</xref>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b066">66</xref>
###xml 972 975 972 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 967 975 967 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rag-1<sup>&#8722;/&#8722;</sup></italic>
###xml 1019 1020 1015 1016 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1093 1095 1089 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050137-b066">66</xref>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
The present study on A2BAR signaling during renal ischemia is consistent with recent work on cardiac generation and signaling of adenosine [63,64]. For example, two recent studies provided genetic evidence for extracellular adenosine generation in cardio-protection by IP [27,28]. In extension of these findings, the authors compared preconditioning responses of gene-targeted mice for each individual AR. Consistent with the present studies and other studies on myocardial pre- or postconditioning [63,64], the authors found a pivotal role of the A2BAR, revealing that A2BAR agonist treatment preconditions the myocardium. Other investigations of renal ischemia and reperfusion injury have found contributions of the A2AAR [29,51,65]. As such, a series of studies of renal ischemia and reperfusion in chimeric mice found that bone marrow-derived cells play an important role in A2AAR-mediated tissue protection [29,65,66]. Further work using adoptive transfers into Rag-1-/- mice revealed that IFNgamma produced by CD4+ T cells appears to be an important mediator for this complex interplay [66]. Taken together with results from the present studies, these findings suggest a combined role of myeloid A2AARs-predominantly expressed on T-lymphocytes-and reno-vascular A2BARs in attenuation of renal ischemia.
###end p 147
###begin p 148
###xml 389 395 <span type="species:ncbi:10090">murine</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 466 471 <span type="species:ncbi:9606">human</span>
In conclusion, the present studies revealed induction and signaling through the reno-vascular A2BAR as part of an endogenous pathway to increase renal resistance to ischemia and attenuate ischemia reperfusion injury. Extensions of these findings provide evidence for targeting the A2BAR therapeutically during renal ischemia. Based on the fact that the presented data are all derived from murine studies, further challenges will include the translation from mice to human. In addition, it will be important to address pharmacokinetics and additional effects of A2BAR agonist treatment on coagulation, blood pressure, or pulmonary function, before such studies can be implemented and tested in a clinical setting.
###end p 148
###begin p 149
###xml 437 441 <span type="species:ncbi:10090">mice</span>
The authors wish to acknowledge Thomas Krahn (Bayer HealthCare AG, Wuppertal, Germany) for kindly providing us the A2BAR agonist BAY 60-6583; Rosemarie Maier, Stephanie Zug, Doris Kloor, and Renate Riehle for excellent technical support; and Shelley Eltzschig for artwork during manuscript preparation. We would like to acknowledge Catherine Ledent, Marlene A. Jacobson, and Juergen Schnermann for kindly providing us with gene-targeted mice.
###end p 149
###begin title 150
Abbreviations
###end title 150
###begin p 151
adenosine receptor
###end p 151
###begin p 152
degree of freedom
###end p 152
###begin p 153
glomerular filtration rate
###end p 153
###begin p 154
hematoxylin and eosin
###end p 154
###begin p 155
interleukin
###end p 155
###begin p 156
inducible nitric oxide synthase
###end p 156
###begin p 157
ischemic preconditioning
###end p 157
###begin p 158
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
###xml 50 55 <span type="species:ncbi:9606">human</span>
keratinocyte-derived chemokine (mouse ortholog of human IL-8)
###end p 158
###begin p 159
knockout
###end p 159
###begin p 160
reverse transcription
###end p 160
###begin p 161
tumor necrosis factor-alpha
###end p 161
###begin p 162
wild type
###end p 162
###begin title 163
References
###end title 163
###begin article-title 164
Normotensive ischemic acute renal failure
###end article-title 164
###begin article-title 165
Acute renal failure
###end article-title 165
###begin article-title 166
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Acute kidney injury, mortality, length of stay, and costs in hospitalized patients
###end article-title 166
###begin article-title 167
The pathophysiology of aortic cross-clamping and unclamping
###end article-title 167
###begin article-title 168
Acute renal failure and cardiac surgery: marching in place or moving ahead
###end article-title 168
###begin article-title 169
Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease
###end article-title 169
###begin article-title 170
Predominant role for C5b-9 in renal ischemia/reperfusion injury
###end article-title 170
###begin article-title 171
Initiation of complement activation following oxidative stress. In vitro and in vivo observations
###end article-title 171
###begin article-title 172
Vasoconstrictor and vasodilator effects of adenosine in the kidney
###end article-title 172
###begin article-title 173
Adenosine and kidney function
###end article-title 173
###begin article-title 174
Cardiac effects of adenosine in A(2A) receptor knockout hearts: uncovering A(2B) receptors
###end article-title 174
###begin article-title 175
Pharmacologic therapeutics for cardiac reperfusion injury
###end article-title 175
###begin article-title 176
Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors
###end article-title 176
###begin article-title 177
Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors
###end article-title 177
###begin article-title 178
Adenosine in tissue protection and tissue regeneration
###end article-title 178
###begin article-title 179
Adenosine, an endogenous distress signal, modulates tissue damage and repair
###end article-title 179
###begin article-title 180
Cardioprotection with adenosine A2 receptor activation at reperfusion
###end article-title 180
###begin article-title 181
A glance at adenosine receptors: novel target for antitumor therapy
###end article-title 181
###begin article-title 182
Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury
###end article-title 182
###begin article-title 183
Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia
###end article-title 183
###begin article-title 184
HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia
###end article-title 184
###begin article-title 185
Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism
###end article-title 185
###begin article-title 186
Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia
###end article-title 186
###begin article-title 187
Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors
###end article-title 187
###begin article-title 188
A2B adenosine receptor dampens hypoxia-induced vascular leak
###end article-title 188
###begin article-title 189
Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation
###end article-title 189
###begin article-title 190
CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury
###end article-title 190
###begin article-title 191
Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors
###end article-title 191
###begin article-title 192
Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells
###end article-title 192
###begin article-title 193
###xml 123 127 <span type="species:ncbi:10090">mice</span>
A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice
###end article-title 193
###begin article-title 194
Clinical practice. Supraventricular tachycardia
###end article-title 194
###begin article-title 195
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Effects of A1 adenosine receptor agonism using N6-cyclohexyl-2'-O-methyladenosine in patients with left ventricular dysfunction
###end article-title 195
###begin article-title 196
Ecto-5'-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo
###end article-title 196
###begin article-title 197
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Impairment of tubuloglomerular feedback regulation of GFR in ecto-5'-nucleotidase/CD73-deficient mice
###end article-title 197
###begin article-title 198
Mitochondria and their role in preconditioning's trigger phase
###end article-title 198
###begin article-title 199
Signaling pathways in ischemic preconditioning
###end article-title 199
###begin article-title 200
GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury
###end article-title 200
###begin article-title 201
The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function
###end article-title 201
###begin article-title 202
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice
###end article-title 202
###begin article-title 203
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Use of a hanging-weight system for isolated renal artery occlusion during ischemic preconditioning in mice
###end article-title 203
###begin article-title 204
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells
###end article-title 204
###begin article-title 205
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors
###end article-title 205
###begin article-title 206
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
###end article-title 206
###begin article-title 207
The A2B adenosine receptor protects against inflammation and excessive vascular adhesion
###end article-title 207
###begin article-title 208
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Resistance of mice lacking the serum- and glucocorticoid-inducible kinase SGK1 against salt-sensitive hypertension induced by a high-fat diet
###end article-title 208
###begin article-title 209
###xml 47 50 <span type="species:ncbi:10116">rat</span>
Tissue levels of S-adenosylhomocysteine in the rat kidney: effects of ischemia and homocysteine
###end article-title 209
###begin article-title 210
An experimental model for assessment of renal recovery from warm ischemia
###end article-title 210
###begin article-title 211
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Diagnostic value of immunostaining for tryptase in patients with mastocytosis
###end article-title 211
###begin article-title 212
Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes
###end article-title 212
###begin article-title 213
Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A(1) and A(3) receptors
###end article-title 213
###begin article-title 214
###xml 38 43 <span type="species:ncbi:9606">human</span>
Preconditioning and adenosine protect human proximal tubule cells in an in vitro model of ischemic injury
###end article-title 214
###begin article-title 215
Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury
###end article-title 215
###begin article-title 216
Physiological roles of 5'-ectonucleotidase (CD73)
###end article-title 216
###begin article-title 217
Ubiquitin signalling in the NF-kappaB pathway
###end article-title 217
###begin article-title 218
The involvement of oxidative stress in the progression of renal injury
###end article-title 218
###begin article-title 219
Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability
###end article-title 219
###begin article-title 220
Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer
###end article-title 220
###begin article-title 221
Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury
###end article-title 221
###begin article-title 222
###xml 95 98 <span type="species:ncbi:10116">rat</span>
Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney
###end article-title 222
###begin article-title 223
Adenosine produced via the CD73/ecto-5'-nucleotidase pathway has no impact on erythropoietin production but is associated with reduced kidney weight
###end article-title 223
###begin article-title 224
Lack of effect of extracellular adenosine generation and signalling on renal erythropoietin secretion during hypoxia
###end article-title 224
###begin article-title 225
Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator
###end article-title 225
###begin article-title 226
###xml 26 32 <span type="species:ncbi:9986">rabbit</span>
Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade
###end article-title 226
###begin article-title 227
###xml 41 47 <span type="species:ncbi:9986">rabbit</span>
Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion
###end article-title 227
###begin article-title 228
Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition
###end article-title 228
###begin article-title 229
Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma
###end article-title 229
###begin p 230
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. AG, HO, TE, KR, and HKE designed the experiments/the study. AG, TE, DY, HZ, KK, and KR collected data or did experiments for the study. AG, ZVT, KK, KR, and HKE analyzed the data. AG, HO, ZVT, KR, and HKE contributed to writing the paper.
###end p 230
###begin p 231
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: This work was supported by a Deutsche Forschungsgemeinschaft (DFG) Research Fellowship (GR2121/1-1) for AG; a Fortune grant 1416-0-0; Interdisciplinary Centre for Clinical Research (IZKF) Verbundprojekt 1597-0-0 from the University of Tubingen; German Research Foundation (DFG) grant EL274/2-2; Foundation for Anesthesia Education and Research Grant (FAER) to HKE; and IZKF Nachwuchsgruppe 1605-0-0 to TE.
###end p 231
###begin p 232
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: Bayer HealthCare has patented the use of the A2BAR agonist BAY 60-6583 in the treatment of different medical conditions. The authors are not associated with Bayer HealthCare and are not involved in the patent application. The authors report no competing interests.
###end p 232

